文献速递妇产影像外周血管US

妊娠11周前超声特征与早孕期母体因素对妊娠期高血压疾病的预测

Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

前瞻性队列纳入1141例单胎妊娠,于5+1至11+0周超声测量孕囊直径、卵黄囊直径、头臀长、胎心率、滋养层厚度与体积及子宫动脉搏动指数,并结合10-14周母体生化指标。55例(4.8%)发生妊娠期高血压疾病,其滋养层体积、PAPP-A与PlGF的MoM值显著降低;包含母体体重、身高及滋养层体积、胎心率、PlGF MoM值的logistic模型AUC为0.80(95%CI 0.75-0.86)。

要点

  • 发生妊娠期高血压疾病者早孕期滋养层体积MoM值显著降低(P=0.006)。
  • PAPP-A(P=0.031)与PlGF(P=0.044)MoM值在后续发生妊娠期高血压疾病者中显著降低。
  • 联合母体体重、身高、滋养层体积、胎心率与PlGF的模型预测AUC为0.80(95%CI 0.75-0.86)。

关键影像表现/征象

  • 早孕期超声测量包括孕囊平均直径、卵黄囊直径、头臀长、胎心率、滋养层厚度、滋养层体积和平均子宫动脉搏动指数。
  • 后续发生妊娠期高血压疾病者滋养层体积MoM值显著降低(P=0.006)。

诊断标准与关键数值

  • 滋养层体积MoM值在后续发生妊娠期高血压疾病者中显著降低(P=0.006)。
  • PAPP-A MoM值在后续发生妊娠期高血压疾病者中显著降低(P=0.031)。
  • PlGF MoM值在后续发生妊娠期高血压疾病者中显著降低(P=0.044)。
  • 所提logistic回归模型纳入母体体重和身高及滋养层体积、胎心率和PlGF的MoM值,AUC为0.80(95%CI 0.75-0.86)。

临床应用与阅片要点

  • 作者结论认为,妊娠11周前母体体重与身高、滋养层体积和胎心率联合早孕期PlGF似乎对后续妊娠期高血压疾病有较好预测价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Maternal hypertensive disorders (MHD), including pregnancy-induced hypertension and pre-eclampsia, are estimated to occur in 7-10% of pregnancies worldwide and have significant short- and long-term implications for both mother and fetus. This study aimed to determine the association of conventional and novel early first-trimester ultrasound measures with MHD and whether these ultrasound measures, combined with maternal characteristics and biochemistry, improve the prediction of MHD.

METHODS: This was a prospective cohort study of consecutive women with a singleton pregnancy, attending for an early (5 + 1 to 11 + 0 weeks' gestation) ultrasound examination at a private obstetric ultrasound practice between February 2016 and August 2018. Recorded ultrasound measurements included mean sac diameter, yolk sac diameter, crown-rump length, fetal heart rate (FHR), trophoblast thickness, trophoblast volume (TV) and mean uterine artery pulsatility index. Maternal biochemistry was assessed at 10-14 weeks and included beta-human chorionic gonadotropin, pregnancy-associated plasma protein-A (PAPP-A), placental growth factor (PlGF) and maternal serum alpha-fetoprotein. Regression models were fitted for each ultrasound parameter and multiples of the median (MoM) were calculated. All measures were compared between women who had a normotensive outcome and those who subsequently developed MHD. Logistic regression analysis was used to create a prediction model for MHD based on maternal characteristics, ultrasound measurements at 5 + 1 to 11 + 0 weeks' gestation and maternal biochemistry at 10-14 weeks.

RESULTS: In total, 1141 women were included in the analysis, of whom 1086 (95.2%) were normotensive at delivery and 55 (4.8%) developed MHD. Women who developed MHD weighed significantly more than did normotensive women (P < 0.0001). Mean MoM values for TV (P = 0.006), PAPP-A (P = 0.031) and PlGF (P = 0.044) were decreased significantly in pregnancies that subsequently developed MHD. The proposed logistic regression model includes maternal weight and height and MoM values for TV, FHR and PlGF, resulting in an area under the receiver-operating-characteristics curve of 0.80 (95% CI, 0.75-0.86).

CONCLUSION: The combination of maternal weight and height, TV and FHR, measured prior to 11 weeks' gestation, and first-trimester PlGF appears to have good predictive value for development of MHD later in pregnancy. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hanchard TJ, de Vries BS, Quinton AE, et al. Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol. 2020. PMID: 31909523. doi:10.1002/uog.21962

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。